|
|
|
Bibliography
The following articles are related to eNOS Pharmaceuticals and to the technology used in our products. Recently published articles are marked with a red asterisk (*).
| |
Endres, Matthias, Laufs, Ulrich, Huang, Zhihong, Nakamura, Tadashi, Huang, Paul, Moskowitz, Michael A., and Liao, James A. (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci 95: 8880-8885.
|
| * |
Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Bohm M, Schoen FJ, Moskowitz MA, Liao JK. (2000) Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest. Jul;106(1):15-24.
|
| |
Morikawa, Eiharu, Moskowitz, Michael A., Huang, Zhihong, Yoshida, Tazuka, Irikura, Katsumi, and Dalkara, Turgay. (1994) L-Arginine Infusion Promotes Nitric Oxide-Dependent Vasodilation, Increase Regional Cerebral Blood Flow, and Reduces Infarction Volume in the Rat. Stroke 25: 429-435.
|
|